Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Cash from Operations (2016 - 2025)

Haemonetics (HAE) has 17 years of Cash from Operations data on record, last reported at 93564000.0 in Q4 2025.

  • For Q4 2025, Cash from Operations rose 113.78% year-over-year to 93564000.0; the TTM value through Dec 2025 reached 338837000.0, up 162.16%, while the annual FY2025 figure was 181725000.0, 0.01% changed from the prior year.
  • Cash from Operations reached 93564000.0 in Q4 2025 per HAE's latest filing, down from 111321000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 116557000.0 in Q1 2025 and bottomed at 27421000.0 in Q2 2024.
  • Average Cash from Operations over 5 years is 51631200.0, with a median of 55628000.0 recorded in 2022.
  • The widest YoY moves for Cash from Operations: up 8204.81% in 2024, down 243.67% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 43460000.0 in 2021, then skyrocketed by 48.22% to 64415000.0 in 2022, then crashed by 100.84% to 540000.0 in 2023, then soared by 8204.81% to 43766000.0 in 2024, then soared by 113.78% to 93564000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 93564000.0 in Q4 2025, 111321000.0 in Q3 2025, and 17395000.0 in Q2 2025.